290 related articles for article (PubMed ID: 25380589)
1. A comprehensive visual rating scale of brain magnetic resonance imaging: application in elderly subjects with Alzheimer's disease, mild cognitive impairment, and normal cognition.
Jang JW; Park SY; Park YH; Baek MJ; Lim JS; Youn YC; Kim S
J Alzheimers Dis; 2015; 44(3):1023-34. PubMed ID: 25380589
[TBL] [Abstract][Full Text] [Related]
2. A comparative study: visual rating scores and the voxel-based specific regional analysis system for Alzheimer's disease on magnetic resonance imaging among subjects with Alzheimer's disease, mild cognitive impairment, and normal cognition.
Li F; Takechi H; Saito R; Ayaki T; Kokuryu A; Kuzuya A; Takahashi R
Psychogeriatrics; 2019 Mar; 19(2):95-104. PubMed ID: 30276926
[TBL] [Abstract][Full Text] [Related]
3. Cognitive and structural magnetic resonance imaging features of Lewy body dementia and Alzheimer's disease.
Rodriguez MJ; Potter E; Shen Q; Barker W; Greig-Custo M; Agron J; Loewenstein D; Duara R
Alzheimers Dement; 2012 May; 8(3):211-8. PubMed ID: 22546353
[TBL] [Abstract][Full Text] [Related]
4. A 'Comprehensive Visual Rating Scale' for predicting progression to dementia in patients with mild cognitive impairment.
Jang JW; Park JH; Kim S; Park YH; Pyun JM; Lim JS; Kim Y; Youn YC; Kim S;
PLoS One; 2018; 13(8):e0201852. PubMed ID: 30125290
[TBL] [Abstract][Full Text] [Related]
5. Responsiveness of magnetic resonance imaging and neuropsychological assessment in memory clinic patients.
Schmand B; Rienstra A; Tamminga H; Richard E; van Gool WA; Caan MW; Majoie CB
J Alzheimers Dis; 2014; 40(2):409-18. PubMed ID: 24473187
[TBL] [Abstract][Full Text] [Related]
6. An MRI brain atrophy and lesion index to assess the progression of structural changes in Alzheimer's disease, mild cognitive impairment, and normal aging: a follow-up study.
Zhang N; Song X; Zhang Y; Chen W; D'Arcy RC; Darvesh S; Fisk JD; Rockwood K;
J Alzheimers Dis; 2011; 26 Suppl 3():359-67. PubMed ID: 21971475
[TBL] [Abstract][Full Text] [Related]
7. Cognitive and neuroimaging profiles in mild cognitive impairment and Alzheimer's disease: data from the Spanish Multicenter Normative Studies (NEURONORMA Project).
Sánchez-Benavides G; Peña-Casanova J; Casals-Coll M; Gramunt N; Molinuevo JL; Gómez-Ansón B; Aguilar M; Robles A; Antúnez C; Martínez-Parra C; Frank-García A; Fernández-Martínez M; Blesa R;
J Alzheimers Dis; 2014; 41(3):887-901. PubMed ID: 24718100
[TBL] [Abstract][Full Text] [Related]
8. Visual rating method and tensor-based morphometry in the diagnosis of mild cognitive impairment and Alzheimer's disease: a comparative magnetic resonance imaging study.
Tuokkola T; Koikkalainen J; Parkkola R; Karrasch M; Lötjönen J; Rinne JO
Acta Radiol; 2016 Mar; 57(3):348-55. PubMed ID: 25977576
[TBL] [Abstract][Full Text] [Related]
9. Olfactory cortex degeneration in Alzheimer's disease and mild cognitive impairment.
Vasavada MM; Wang J; Eslinger PJ; Gill DJ; Sun X; Karunanayaka P; Yang QX
J Alzheimers Dis; 2015; 45(3):947-58. PubMed ID: 25633674
[TBL] [Abstract][Full Text] [Related]
10. Visual rating system for assessing magnetic resonance images: a tool in the diagnosis of mild cognitive impairment and Alzheimer disease.
Urs R; Potter E; Barker W; Appel J; Loewenstein DA; Zhao W; Duara R
J Comput Assist Tomogr; 2009; 33(1):73-8. PubMed ID: 19188789
[TBL] [Abstract][Full Text] [Related]
11. Correlating Cognitive Decline with White Matter Lesion and Brain Atrophy Magnetic Resonance Imaging Measurements in Alzheimer's Disease.
Bilello M; Doshi J; Nabavizadeh SA; Toledo JB; Erus G; Xie SX; Trojanowski JQ; Han X; Davatzikos C
J Alzheimers Dis; 2015; 48(4):987-94. PubMed ID: 26402108
[TBL] [Abstract][Full Text] [Related]
12. Discerning mild cognitive impairment and Alzheimer Disease from normal aging: morphologic characterization based on univariate and multivariate models.
Liao W; Long X; Jiang C; Diao Y; Liu X; Zheng H; Zhang L;
Acad Radiol; 2014 May; 21(5):597-604. PubMed ID: 24433704
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of whole brain health in aging and Alzheimer's disease: a standard procedure for scoring an MRI-based brain atrophy and lesion index.
Guo H; Song X; Schmidt MH; Vandorpe R; Yang Z; LeBlanc E; Zhang J; Beyea S; Zhang Y; Rockwood K
J Alzheimers Dis; 2014; 42(2):691-703. PubMed ID: 24927702
[TBL] [Abstract][Full Text] [Related]
14. Cognition, brain atrophy, and cerebrospinal fluid biomarkers changes from preclinical to dementia stage of Alzheimer's disease and the influence of apolipoprotein e.
Susanto TA; Pua EP; Zhou J;
J Alzheimers Dis; 2015; 45(1):253-68. PubMed ID: 25524955
[TBL] [Abstract][Full Text] [Related]
15. Clinical and demographic predictors of mild cognitive impairment for converting to Alzheimer's disease and reverting to normal cognition.
Tokuchi R; Hishikawa N; Kurata T; Sato K; Kono S; Yamashita T; Deguchi K; Abe K
J Neurol Sci; 2014 Nov; 346(1-2):288-92. PubMed ID: 25248955
[TBL] [Abstract][Full Text] [Related]
16. Dynamics of brain structure and cognitive function in the Alzheimer's disease neuroimaging initiative.
Song X; Mitnitski A; Zhang N; Chen W; Rockwood K;
J Neurol Neurosurg Psychiatry; 2013 Jan; 84(1):71-8. PubMed ID: 23123510
[TBL] [Abstract][Full Text] [Related]
17. IVIG treatment of mild cognitive impairment due to Alzheimer's disease: a randomised double-blinded exploratory study of the effect on brain atrophy, cognition and conversion to dementia.
Kile S; Au W; Parise C; Rose K; Donnel T; Hankins A; Chan M; Ghassemi A
J Neurol Neurosurg Psychiatry; 2017 Feb; 88(2):106-112. PubMed ID: 26420886
[TBL] [Abstract][Full Text] [Related]
18. Comparison of imaging biomarkers for Alzheimer's disease: amyloid imaging with [18F]florbetapir positron emission tomography and magnetic resonance imaging voxel-based analysis for entorhinal cortex atrophy.
Tateno A; Sakayori T; Kawashima Y; Higuchi M; Suhara T; Mizumura S; Mintun MA; Skovronsky DM; Honjo K; Ishihara K; Kumita S; Suzuki H; Okubo Y
Int J Geriatr Psychiatry; 2015 May; 30(5):505-13. PubMed ID: 25043833
[TBL] [Abstract][Full Text] [Related]
19. Volumetric and visual rating of magnetic resonance imaging scans in the diagnosis of amnestic mild cognitive impairment and Alzheimer's disease.
Shen Q; Loewenstein DA; Potter E; Zhao W; Appel J; Greig MT; Raj A; Acevedo A; Schofield E; Barker W; Wu Y; Potter H; Duara R
Alzheimers Dement; 2011 Jul; 7(4):e101-8. PubMed ID: 21784342
[TBL] [Abstract][Full Text] [Related]
20. Volumes of lateral temporal and parietal structures distinguish between healthy aging, mild cognitive impairment, and Alzheimer's disease.
Hänggi J; Streffer J; Jäncke L; Hock C
J Alzheimers Dis; 2011; 26(4):719-34. PubMed ID: 21709375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
